[ad_1] Y Intercept Hong Kong Ltd purchased a new position in Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) during the 1st quarter, according to the company in its most recent…
Tag: Gossamer
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
[ad_1] – FDA Feedback on Seralutinib Phase 3 Clinical Trial Received; Expected to Commence in the Second Half of 2023 – – Topline Data from TORREY Study Open-Label Extension Expected…